Heron Therapeutics (HRTX) extends Tax Benefit Preservation Plan to 2029
Rhea-AI Filing Summary
Heron Therapeutics, Inc. entered into Amendment No. 1 to its Tax Benefit Preservation Plan with Computershare Trust Company, N.A. as rights agent. The amendment changes the Plan’s definition of “Final Expiration Date,” extending all prior references to August 14, 2026 to now mean August 14, 2029. This effectively prolongs the duration of the Tax Benefit Preservation Plan by three years. The change is described as a material definitive agreement and as a material modification to the rights of security holders, with the full amendment filed as Exhibit 4.1 and incorporated by reference.
Positive
- None.
Negative
- None.
8-K Event Classification
3 items: 1.01, 3.03, 9.01
3 items
Item 1.01
Entry into a Material Definitive Agreement
Business
The company signed a significant contract such as a merger agreement, credit facility, or major partnership.
Item 3.03
Material Modification to Rights of Security Holders
Securities
A change was made that materially affects the rights of existing shareholders (e.g., dividend rights, voting rights).
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Key Figures
Original Final Expiration Date: August 14, 2026
New Final Expiration Date: August 14, 2029
Amendment Date: August 13, 2026
+1 more
4 metrics
Original Final Expiration Date
August 14, 2026
Prior Final Expiration Date referenced in the Tax Benefit Preservation Plan
New Final Expiration Date
August 14, 2029
Revised Final Expiration Date set by Amendment No. 1
Amendment Date
August 13, 2026
Date Heron Therapeutics entered into Amendment No. 1
Report Signature Date
August 14, 2026
Date the current report was signed on behalf of Heron Therapeutics
Key Terms
Tax Benefit Preservation Plan, Final Expiration Date, rights agent, material modification to the rights of security holders
4 terms
Tax Benefit Preservation Plan financial
"entered into Amendment No. 1 to Tax Benefit Preservation Plan"
A tax benefit preservation plan is a company policy and set of legal steps designed to protect valuable tax attributes—like carryforward losses or credits—from being lost if ownership changes. Think of it as locking up a store’s coupons so a new owner can’t void them; preserving those tax items can lower future tax bills and effectively increase the company’s value, so investors watch these plans as protection of potential after‑tax cash flows.
Final Expiration Date financial
"amends the definition of “Final Expiration Date” and all references"
rights agent financial
"by and between Heron Therapeutics, Inc. and Computershare Trust Company, N.A., as rights agent"
A rights agent is a neutral third party, usually a bank or trust company, that runs the mechanical parts of a company’s rights offering — tracking who gets rights, processing requests to buy additional shares, collecting payments, and issuing the new stock. For investors, the rights agent ensures the offer is handled correctly and on time, which affects the ability to exercise rights and the perceived fairness and legality of the transaction.
material modification to the rights of security holders regulatory
"Material Modification to Rights of Security Holders"
FAQ
What did Heron Therapeutics (HRTX) change in its Tax Benefit Preservation Plan?
Heron Therapeutics amended its Tax Benefit Preservation Plan to extend the “Final Expiration Date” from August 14, 2026 to August 14, 2029. This lengthens the period during which the plan remains in effect for shareholders.
Why is the Heron Therapeutics (HRTX) amendment deemed a material agreement?
The amendment is classified as an entry into a material definitive agreement because it changes the Final Expiration Date of the Tax Benefit Preservation Plan to August 14, 2029, affecting how long the plan governs shareholder rights.
How does the Heron Therapeutics (HRTX) filing affect security holder rights?
The company identifies the amendment as a material modification to the rights of security holders, since extending the Final Expiration Date to August 14, 2029 changes the duration during which the Tax Benefit Preservation Plan applies.
Who is the rights agent under Heron Therapeutics’ (HRTX) Tax Benefit Preservation Plan?
Computershare Trust Company, N.A. serves as the rights agent under the Tax Benefit Preservation Plan, including as amended on August 13, 2026 by Amendment No. 1 filed as Exhibit 4.1.
Where can investors see the full Heron Therapeutics (HRTX) amendment document?
The full text of Amendment No. 1 to the Tax Benefit Preservation Plan is filed as Exhibit 4.1 and is incorporated by reference into the current report detailing the change.
When was the Heron Therapeutics (HRTX) amendment approved and filed?
Heron Therapeutics entered into Amendment No. 1 on August 13, 2026, and the report was signed on the company’s behalf on August 14, 2026 by its Executive Vice President and Chief Financial Officer.
AI-generated analysis. How Rhea-AI works. Not financial advice.
